As Cigna Corporation (CI) Stock Value Rose, Sanders Capital LLC Has Decreased by $119.72 Million Its Stake

February 24, 2018 - By Jan Rainey

Investors sentiment is 0.96 in 2017 Q3. Its the same as in 2017Q2. It is the same, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Royal Bancshares Of Canada holds 353,319 shares or 0.03% of its portfolio. Thompson Siegel Walmsley Llc stated it has 0.18% of its portfolio in Cigna Corporation (NYSE:CI). Keybank National Association Oh accumulated 154,854 shares. 32,980 are held by Timessquare Capital Mngmt Limited Liability Corp. Etrade Management Ltd Liability reported 0.03% stake. Qci Asset Mgmt invested in 0% or 39 shares. Jacobs Levy Equity Mngmt Incorporated invested in 6,229 shares. Moreover, Alphaone Svcs Ltd Liability has 0% invested in Cigna Corporation (NYSE:CI). 4,861 were accumulated by Livforsakringsbolaget Skandia Omsesidigt. Moreover, Jane Street Grp Inc Limited Liability Corporation has 0% invested in Cigna Corporation (NYSE:CI) for 3,220 shares. Aqr Cap Management Ltd holds 0.42% or 1.90 million shares. Bluecrest Capital Ltd invested in 0.3% or 39,128 shares. Exxonmobil Management Tx has invested 0.22% of its portfolio in Cigna Corporation (NYSE:CI). First Tru Advsrs Ltd Partnership owns 127,475 shares. Cornerstone Advisors holds 15,000 shares.

Since September 12, 2017, it had 0 insider purchases, and 8 insider sales for $8.84 million activity. Another trade for 28,037 shares valued at $5.77M was made by MURABITO JOHN M on Wednesday, January 10. HARRIS ISAIAH JR sold $45,762 worth of Cigna Corporation (NYSE:CI) on Tuesday, September 12. 5,971 Cigna Corporation (NYSE:CI) shares with value of $1.29M were sold by ZARCONE DONNA F. ZOLLARS WILLIAM D sold $43,604 worth of stock or 212 shares.

Sanders Capital Llc decreased its stake in Cigna Corporation (CI) by 16.53% based on its latest 2017Q3 regulatory filing with the SEC. Sanders Capital Llc sold 586,883 shares as the company’s stock rose 11.09% with the market. The institutional investor held 2.96 million shares of the medical specialities company at the end of 2017Q3, valued at $604.98 million, down from 3.55M at the end of the previous reported quarter. Sanders Capital Llc who had been investing in Cigna Corporation for a number of months, seems to be less bullish one the $47.52 billion market cap company. The stock increased 1.51% or $2.89 during the last trading session, reaching $194.79. About 1.12 million shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since February 24, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Sanders Capital Llc, which manages about $15.69B and $17.96B US Long portfolio, upped its stake in Jpmorgan Chase & Co (NYSE:JPM) by 141,400 shares to 6.15M shares, valued at $645.88 million in 2017Q3, according to the filing. It also increased its holding in Medtronic Plc (NYSE:MDT) by 711,535 shares in the quarter, for a total of 7.38M shares, and has risen its stake in Cabot Oil & Gas Corp (NYSE:COG).

Analysts await Cigna Corporation (NYSE:CI) to report earnings on May, 4. They expect $3.38 earnings per share, up 22.02 % or $0.61 from last year’s $2.77 per share. CI’s profit will be $824.60M for 14.41 P/E if the $3.38 EPS becomes a reality. After $1.94 actual earnings per share reported by Cigna Corporation for the previous quarter, Wall Street now forecasts 74.23 % EPS growth.

More news for Cigna Corporation (NYSE:CI) were recently published by: Businesswire.com, which released: “Cigna Increases Minimum Wage to $16 an Hour and Further Accelerates …” on January 31, 2018. Businesswire.com‘s article titled: “Cigna Corporation Announces Appearance at the Barclays Global Healthcare …” and published on January 31, 2018 is yet another important article.

Cigna Corporation (NYSE:CI) Ratings Coverage

Among 20 analysts covering CIGNA (NYSE:CI), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. CIGNA had 59 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Friday, February 2 by Morgan Stanley. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, May 8. The firm has “Buy” rating by Piper Jaffray given on Tuesday, October 31. The company was maintained on Thursday, February 1 by Piper Jaffray. Oppenheimer maintained the stock with “Buy” rating in Thursday, June 15 report. The firm has “Buy” rating given on Monday, August 7 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Monday, November 9 with “Sector Perform”. As per Monday, July 27, the company rating was upgraded by Sterne Agee CRT. RBC Capital Markets maintained it with “Buy” rating and $185.0 target in Monday, September 11 report. The firm earned “Outperform” rating on Thursday, June 22 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: